The John Radcliffe Hospital is a large tertiary teaching hospital in Oxford, England. It forms part of the Oxford University Hospitals NHS Foundation Trust and is named after John Radcliffe, an 18th-century ...

During the past decade, Oxford University Hospitals NHS Foundation Trust conducted 236 clinical trials. In the 10-year time frame, 236 clinical trials started and 41 clinical trials were completed, i.e. on average, 17.4% percent of trials that started reached the finish line to date. In the past 5 years, 103 clinical trials started and 30 clinical trials were completed. i.e. 29.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Oxford University Hospitals NHS Foundation Trust" #1 sponsor was "University of Oxford" with 58 trials, followed by "Oxford University Hospitals NHS Trust" with 19 trials sponsored, "Pfizer" with 11 trials sponsored, "Gilead Sciences" with 9 trials sponsored and "Janssen Research & Development, LLC" with 9 trials sponsored. Other sponsors include 161 different institutions and companies that sponsored additional 122 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Oxford University Hospitals NHS Foundation Trust" #1 collaborator was "Oxford University Hospitals NHS Trust" with 31 trials as a collaborator, "National Institute for Health Research, United Kingdom" with 22 trials as a collaborator, "University of Oxford" with 13 trials as a collaborator, "Cancer Research UK" with 7 trials as a collaborator and "King's College London" with 7 trials as a collaborator. Other collaborators include 423 different institutions and companies that were collaborators in the rest 288 trials.

According to Clinical.Site data, the most researched conditions in "Oxford University Hospitals NHS Foundation Trust" are "Ovarian Cancer" (6 trials), "Atrial Fibrillation" (5 trials), "Crohn's Disease" (5 trials), "Lung Cancer" (5 trials) and "Prostate Cancer" (5 trials). Many other conditions were trialed in "Oxford University Hospitals NHS Foundation Trust" in a lesser frequency.

Most popular intervention types in "Oxford University Hospitals NHS Foundation Trust" are "Drug" (124 trials), "Other" (47 trials), "Procedure" (33 trials), "Device" (27 trials) and "Biological" (23 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (38 trials), "Rituximab" (6 trials), "Azacitidine" (4 trials), "Filgotinib" (4 trials) and "Cyclophosphamide" (3 trials). Other intervention names were less common.

The vast majority of trials in "Oxford University Hospitals NHS Foundation Trust" are 234 trials for "All" genders, 20 trials for "Male" genders and 16 trials for "Female" genders.

Currently, there are 115 active trials in "Oxford University Hospitals NHS Foundation Trust". 3 are not yet recruiting, 74 are recruiting, 36 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 107 completed trials in Oxford University Hospitals NHS Foundation Trust, undefined suspended trials, and 26 terminated clinical trials to date.

Out of the total trials that were conducted in Oxford University Hospitals NHS Foundation Trust, 47 "Phase 1" clinical trials were conducted, 66 "Phase 2" clinical trials and 44 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 63 trials that are defined as “Not Applicable".

Oxford University Hospitals NHS Foundation Trust has several departments that took part in Clinical trials: "Churchill Hospital; Oxford Cancer and Haematology Centre" - 17 trials, "Oxford Childrens Hospital" - 7 trials, "Oxford University Hospitals NHS Trust- Churchill Hospital-Oxford Centre for Respiratory Medicine" - 7 trials, "Churchill Hospital; Department of Oncology" - 4 trials, "Nuffield Orthopaedic Centre" - 28 trials, "Oxford Cancer Centre" - 3 trials, "Oxford Heart Centre" - 2 trials, "Emergency Department, John Radcliffe Hospital" - 2 trials